0001571469-24-000001.txt : 20241120 0001571469-24-000001.hdr.sgml : 20241120 20241119190632 ACCESSION NUMBER: 0001571469-24-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241120 DATE AS OF CHANGE: 20241119 EFFECTIVENESS DATE: 20241120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avenzo Therapeutics, Inc. CENTRAL INDEX KEY: 0001947742 ORGANIZATION NAME: IRS NUMBER: 883737798 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-460216 FILM NUMBER: 241477809 BUSINESS ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 380 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: (386) 303-1178 MAIL ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 380 CITY: SAN DIEGO STATE: CA ZIP: 92122 D/A 1 primary_doc.xml X0708 D/A LIVE 0001947742 Avenzo Therapeutics, Inc. 12707 High Bluff Drive, Suite 200 SAN DIEGO CA CALIFORNIA 92130 858-239-2944 DELAWARE None None Corporation true 2022 Athena Countouriotis 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Executive Officer Director Brian Sun 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Executive Officer Mohammad Hirmand 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Executive Officer Simeon George 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Director Carl Gordon 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Director Jakob Dupont, M.D., M.A. 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Director Paolo Tombesi 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Executive Officer Scott Lipman 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Executive Officer Judith Li 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Director Garry Nicholson 12707 High Bluff Drive, Suite 200 San Diego CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06b true 0001947742-24-000002 2022-09-14 false true false 0 385850004 385850004 0 false 22 0 0 0 false Avenzo Therapeutics, Inc. /s/ Athena Countouriotis Athena Countouriotis, M.D. Chief Executive Officer 2024-11-19